ADEPT-2 A study to assess efficacy and safety of KarXT for the treatment of psychosis associated with Alzheimer's disease Dementia-related psychosis or Agitation in Alzheimer's dementia Sponsor Karuna Therapeutics Clinical Trial Phase III Status Ongoing studies but not recruiting Drug KarXT
ADEPT-4 A study to evaluate KarXT as a treatment for psychosis associated with Alzheimer's disease Dementia-related psychosis or Agitation in Alzheimer's dementia Sponsor Karuna Therapeutics Clinical Trial Phase III Status Currently recruiting Drug KarXT
evoke evoke - A research study investigating Semaglutide in people with early Alzheimer's disease Prodromal/Mild Cognitive Impairment due to Alzheimer’s disease Mild Alzheimer's dementia Sponsor Novo Nordisk A/S Clinical Trial Phase III Status Ongoing studies but not recruiting Drug Semaglutide
evoke+ evoke+ - A research study investigating Semaglutide in people with early Alzheimer's disease Prodromal/Mild Cognitive Impairment due to Alzheimer’s disease Mild Alzheimer's dementia Sponsor Novo Nordisk A/S Clinical Trial Phase III Status Ongoing studies but not recruiting Drug Semaglutide
INFRONT-3 A Phase 3 study to evaluate efficacy and safety of AL001 in frontotemporal dementia Frontotemporal dementia Sponsor Alector Inc. Clinical Trial Phase III Status Ongoing studies but not recruiting Drug AL001
Mental imagery Imagery in Early Stages of Dementia Prodromal/Mild Cognitive Impairment due to Alzheimer’s disease Mild Alzheimer's dementia Sponsor University of West Attica Clinical Trial Lifestyle behaviour & intervention Status Currently recruiting Drug Mental imagery
Full member Πανελλήνια Ομοσπονδία Νόσου Alz-heimer και Συναφών Διαταραχών (Panhellenic Federation of Alzheimer’s Disease and Related Disorders) Greece
